Silver bulls lead ASX explorers higher
Gold has been grabbing the headlines as it ventures above the US$3000/oz mark, but the quiet achievers have been silver stocks.
Stockhead
Nanosonics shares soar on FDA approval
The US Food and Drug Administration has approved Nanosonics’ next-generation medical probe sterilising device, dubbed Coris.
WCN closer to Great Bear drilling
White Cliff Minerals has executed an exploration agreement with the Délınę Got ̨ ’ınę government that facilitates exploration at Great Bear.
Imricor raises $70 million for growth
Imricor Medical Systems has received firm commitments to raise $70 million via a strongly supported placement to new and existing institutional and sophisticated investors.
More Stories
Research firm cheers PH2’s growing orders
Pure Hydrogen’s growing order book for zero emissions vehicles validates its strategy to provide transport solutions based on heavy hydrogen fuel cell vehicles.
Emvision’s stroke detector passes first high-flying test
Royal Flying Doctor Service paramedics have successfully tested Emvision’s portable stroke detector, First Responder.
Stockhead Long Shortz with Botanix Pharmaceuticals
Botanix Pharmaceuticals Howie McKibbon drops by the Stockhead TV studio for an update on the company’s inclusion on the ASX300.
StockTake: Asra Minerals
Asra Minerals has completed an extensive target definition program across its Leonora Gold North and South projects.
FDA approval remains Holy Grail for Aussie biotechs
Despite concerns about the Trump government’s shake-up of the agency, the US Food and Drug Administration remains the first port of call for most ASX biotechs.
Nova Minerals set to burst out of production blocks
As gold prices rise to all-time highs beyond US$3000/oz, Nova’s Estelle project in Alaska is emerging as a major gold and antimony development prospect.
ASX pharmas playing the long game
ASX pharmaceutical companies are retaining their assets longer and advancing them to commercialisation in a bid to maximise value.
OMA rated a speculative buy by Morgans
Omega Oil and Gas has been judged a speculative buy with a 64c price target by Morgans as it flow tests its Canyon-1H well.
Spectacular visible gold lifts Trek
Trek Metals is on the hunt for a deposit of major scale and has picked up the pace of exploration at Christmas Creek in the Kimberley, not far south of Halls Creek.
RML survey to identify new antimony targets
Resolution Minerals LiDAR survey aimed at generating new targets at its recently acquired Drake East antimony-gold project in NSW.
Original URL: https://www.thechronicle.com.au/business/stockhead/page/5